Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2025-12-24 @ 10:37 PM
NCT ID:
NCT02935335
Eligibility Criteria:
Inclusion Criteria:
* Women aged between \[18-42\] years.
* Both ovaries present.
* Regular menstrual cycles presumed to be ovulatory.
* Primary or secondary infertility of any origin for more than 12 months.
* Patient with at least one result of antimüllerian hormone (AMH) measured by a fully automated assay available before inclusion, and performed in the past 12 months before inclusion.
* Candidates eligible to a first IVF/ICSI cycle and for whom Menopur® HP-hMG 600 IU/mL has been prescribed.
* Having received oral and written information on the study, without any objections for the use of his/her anonymized data, and having signed a written Informed Consent Form.
Exclusion Criteria:
* Major uterine or ovarian morphological abnormalities or past ovarian surgery.
* Endometriosis stage III/IV.
* Polycystic ovarian syndrome.
* Major endocrine or metabolic abnormalities without treatment.
* Patient included in an interventional study assessing treatment for infertility.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
42 Years
Study:
NCT02935335
Study Brief:
Protocol Section:
NCT02935335